[
  {
    "publication_date": "2026-01-23",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Magnus Essand",
    "person_in_leading_position": "Magnus Essand",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Lån mottaget",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2026-01-22",
    "volume": 280000.0,
    "volume_raw": "280000,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-27",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Jamal El Mosleh",
    "person_in_leading_position": "Jamal El Mosleh",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Aktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-05-27",
    "volume": 20000.0,
    "volume_raw": "20000,0",
    "volume_unit": "Antal",
    "price": 6.59,
    "price_raw": "6,59",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 131800.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-27",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Jamal El Mosleh",
    "person_in_leading_position": "Jamal El Mosleh",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Aktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-05-26",
    "volume": 25000.0,
    "volume_raw": "25000,0",
    "volume_unit": "Antal",
    "price": 7.06,
    "price_raw": "7,06",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 176500.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-27",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Jamal El Mosleh",
    "person_in_leading_position": "Jamal El Mosleh",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Aktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-05-23",
    "volume": 102500.0,
    "volume_raw": "102500,0",
    "volume_unit": "Antal",
    "price": 6.51,
    "price_raw": "6,51",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 667275.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-27",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Jamal El Mosleh",
    "person_in_leading_position": "Jamal El Mosleh",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Aktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-05-22",
    "volume": 237500.0,
    "volume_raw": "237500,0",
    "volume_unit": "Antal",
    "price": 6.3,
    "price_raw": "6,3",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 1496250.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-12",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Margareth Jorvid",
    "person_in_leading_position": "Margareth Jorvid",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Interimsaktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-03-11",
    "volume": 21700.0,
    "volume_raw": "21700,0",
    "volume_unit": "Antal",
    "price": 1.85,
    "price_raw": "1,85",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 40145.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-12",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Magnus Essand",
    "person_in_leading_position": "Magnus Essand",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Interimsaktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-03-11",
    "volume": 43211.0,
    "volume_raw": "43211,0",
    "volume_unit": "Antal",
    "price": 1.85,
    "price_raw": "1,85",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 79940.35,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-12",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Agneta Edberg",
    "person_in_leading_position": "Agneta Edberg",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Interimsaktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-03-11",
    "volume": 27027.0,
    "volume_raw": "27027,0",
    "volume_unit": "Antal",
    "price": 1.85,
    "price_raw": "1,85",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 49999.950000000004,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-12",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Christina Herder",
    "person_in_leading_position": "Christina Herder",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Interimsaktie",
    "instrument_name": "Elicera Therapeutics",
    "isin": "SE0024173025",
    "transaction_date": "2025-03-11",
    "volume": 21700.0,
    "volume_raw": "21700,0",
    "volume_unit": "Antal",
    "price": 1.85,
    "price_raw": "1,85",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 40145.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-11",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Di Yu",
    "person_in_leading_position": "Di Yu",
    "position": "Styrelsesuppleant",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Interimsaktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0024173025",
    "transaction_date": "2025-03-11",
    "volume": 50000.0,
    "volume_raw": "50000,0",
    "volume_unit": "Antal",
    "price": 1.85,
    "price_raw": "1,85",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 92500.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-11",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Jamal El Mosleh",
    "person_in_leading_position": "Jamal El Mosleh",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Interimsaktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-03-11",
    "volume": 151900.0,
    "volume_raw": "151900,0",
    "volume_unit": "Antal",
    "price": 1.85,
    "price_raw": "1,85",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 281015.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-11",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Rolf Ingvar Lennart Karlsson",
    "person_in_leading_position": "Rolf Ingvar Lennart Karlsson",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Interimsaktie",
    "instrument_name": "Elicera Therapeutics AB",
    "isin": "SE0015382080",
    "transaction_date": "2025-03-11",
    "volume": 51600.0,
    "volume_raw": "51600,0",
    "volume_unit": "Antal",
    "price": 1.85,
    "price_raw": "1,85",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 95460.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-03-11",
    "issuer": "Elicera Therapeutics AB",
    "lei": "549300I35L0R4INBFG27",
    "reporting_person": "Rolf Ingvar Lennart Karlsson",
    "person_in_leading_position": "Rolf Ingvar Lennart Karlsson",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Option",
    "instrument_name": "Elicera Therapeutics AB TO2",
    "isin": "SE0021626314",
    "transaction_date": "2025-03-10",
    "volume": 18000.0,
    "volume_raw": "18000,0",
    "volume_unit": "Antal",
    "price": 0.5,
    "price_raw": "0,50",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 9000.0,
    "status": "Aktuell",
    "is_current_report": true
  }
]